Premium
Effectiveness of Influenza Vaccine in Hemodialyzed Patients: A Retrospective Study
Author(s) -
CohenHagai Keren,
Kotliroff Andy,
Rozenberg Ilan,
Korzets Zeev,
ZitmanGal Tali,
Benchetrit Sydney
Publication year - 2019
Publication title -
therapeutic apheresis and dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.415
H-Index - 53
eISSN - 1744-9987
pISSN - 1744-9979
DOI - 10.1111/1744-9987.12742
Subject(s) - medicine , vaccination , incidence (geometry) , hemodialysis , dialysis , retrospective cohort study , diabetes mellitus , influenza vaccine , population , intensive care medicine , immunology , physics , environmental health , optics , endocrinology
Infection is one of the leading causes of mortality in dialysis patients, second only to cardiovascular disease. This retrospective study assessed the efficacy and clinical outcomes of influenza vaccination among hemodialysis (HD) patients. In the 2014–2015 season, 104 of 164 (63.6%) HD patients were vaccinated for influenza by the outpatient community health system facilities. Significantly more patients, 159 of 170 (93.8%), were vaccinated in 2015–2016 by the hospital dialysis unit staff during an inpatient HD session ( P <0.001). A trend toward fewer complications from influenza infection was observed in vaccinated patients. Among HD patients with diabetes (who comprised 56% of the study population), the incidence of influenza was 17% among nonvaccinated patients vs. 6.3% among those who were vaccinated ( P =0.026). The inpatient vaccination policy resulted in a greater rate of vaccination. HD patients with diabetes benefit from influenza vaccination, with a significantly lower incidence of influenza infection.